Machine learning predictions based on historical earnings data and price patterns
1-Day Prediction
+2.88%
$0.72
0% positive prob.
5-Day Prediction
-3.90%
$0.67
0% positive prob.
20-Day Prediction
-37.66%
$0.44
0% positive prob.
SEC 8-K filings with transcript text
Nov 17, 2025 · 100% conf.
1D
+2.88%
$0.72
Act: +0.00%
5D
-3.90%
$0.67
Act: -1.59%
20D
-37.66%
$0.44
Act: -28.30%
cosm_8k.htm0001474167false00014741672025-11-172025-11-17iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 17, 2025
Cosmos Health Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
5 AGIOU GEORGIOU, Pilea, Thessaloniki, Greece
55438
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 865-0026
(Former name or former address, if changed since last report.)
Title of Each Class
Trading Symbol
Name of Each Exchange On Which Registered
Common Stock, $.001 par value
The Nasdaq Stock Market LLC
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On November 17, 2025, Cosmos Health Inc., a Nevada corporation (the “Company”), issued a press release announcing its financial results for the quarter and nine months ended September 30, 2025. A copy of the Company’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference in this Item 2.02.
The information set forth in Item 2.02 of this Current Report on Form 8-K is incorporated by reference in this Item 7.01.
In accordance with General Instruction B.2 to Form 8-K, the information set forth in the Items 2.02 and 7.01 and in Exhibit 99.1 hereto, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in that filing.
By furnishing this Current Report on Form 8-K, the Company makes no admission as to the materiality of any information in this Current Report on Form 8-K, including the statements made in Items 2.02 and 7.01 above and in Exhibit 99.1 hereto.
(d) Exhibits
Exhibit No.
Description
99.1
Press Release issued by Cosmos Health Inc., dated November 17, 2025.
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 17, 2025 By: /s/ Georgios Terzis
Georgios Terzis
Chief Financial Officer
3
Nov 22, 2023
cosm_8k.htm0001474167false00014741672023-11-212023-11-21iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 21, 2023
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece
55438
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 536-3102
N/A (Former name or former address, if changed since last report.)
Title of Each Class
Trading Symbol
Name of Each Exchange On Which Registered
Common Stock, $.001 par value
Nasdaq Capital Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
A copy of the press release dated November 21, 2023 of Cosmos Health Inc. titled “Cosmos Health Reports Third Quarter 2023 Financial Results” is filed as Exhibit 99.1 to this Report on Form 8-K. The release contains additional non-public information to that contained in the Company’s current report on Form 10-Q filed with the SEC on November 20, 2023.
(d) Exhibits
Number
99.1 Press Release dated November 21, 2023, titled “Cosmos Health Reports Third Quarter 2023 Financial Results”.
104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 22, 2023 By: /s/ Georgios Terzis
Georgios Terzis
Chief Financial Officer
3
Aug 15, 2023
cosm_8k.htm0001474167false00014741672023-08-152023-08-15iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 15, 2023
Cosmos Health Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
141 West Jackson Blvd, Suite 4236, Chicago, Illinois
60604
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 865-0026
N/A (Former name or former address, if changed since last report.)
Title of Each Class
Trading Symbol
Name of Each Exchange On Which Registered
Common Stock, $.001 par value
Nasdaq Capital Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION
A copy of the Company’s Press Release dated August 15, 2023 titled: “Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04” is filed as Exhibit 99.1 to this Report on Form 8-K.
(d) Exhibits
99.1
Press Release dated August 15, 2023 titled “Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04.”
104
Cover Page Interactive Data File (embedded within the Inline XBRL Document)
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 15, 2023 By: /s/ Georgios Terzis
Georgios Terzis
Chief Financial Officer
3
Apr 18, 2023
cosm_8k.htm0001474167false00014741672023-04-132023-04-13iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) April 13, 2023
Cosmos Health Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
141 West Jackson Blvd, Suite 4236, Chicago, Illinois
60604
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 865-0026
N/A (Former name or former address, if changed since last report.)
Title of Each Class
Trading Symbol
Name of Each Exchange On Which Registered
Common Stock, $.001 par value
Nasdaq Capital Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
A copy of the Company’s press release dated April 13, 2023 titled: “Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022” is filed as Exhibit 99.1 to this Current Report on Form 8-K.
(d) Exhibits
Number
99.1 Press Release dated April 13, 2023 titled: “Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022.”
104 Cover Page Interactive Data File (embedded within the Inline XBRL Document)
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 18, 2023 By: /s/ Georgios Terzis
Georgios Terzis
Chief Financial Officer
3
Nov 16, 2022
cosm_8k.htm0001474167false00014741672022-11-102022-11-10iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 10, 2022
Cosmos Holdings Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
141 West Jackson Blvd, Suite 4236, Chicago, Illinois
60604
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 865-0026
N/A (Former name or former address, if changed since last report.)
Title of Each Class
Trading Symbol
Name of Each Exchange On Which Registered
Common Stock, $.001 par value
Nasdaq Capital Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
A copy of the press release dated November 15, 2022 of Cosmos Holdings, Inc. (d/b/a Cosmos Health, Inc.) titled “Cosmos Health Reports Third Quarter 2022 Financial Results” is filed as Exhibit 99.1 to this Report on Form 8-K. The release contains additional non-public information to that contained in the Company’s current report on Form 10-Q filed with the SEC on November 14, 2022.
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On November 10, 2022, Cosmos Holdings Inc. (the “Company”) received a non-compliance letter from the Nasdaq Stock Market for its failure to maintain a minimum closing bid price of $0.10 per share for ten (10) consecutive business days in accordance with Nasdaq Listing Rule 5810(c)(3)(A)(ii). Pursuant to a prior non-compliance letter from Nasdaq dated July 26, 2022, the Company had until January 23, 2023 to regain compliance by the closing bid price of the Company’s common stock being at least $1.00 per share for ten (10) consecutive trading days. The Staff has determined to suspend trading of the Company’s securities on November 21, 2022 and delist the Company’s securities. However, the Company has requested an appeal of the delisting determination by requesting a hearing to stay the automatic suspension of the Company’s securities on November 21, 2022 and the filing of a Form 25-NSE with the SEC to remove the Company’s securities from listing and registration on the Nasdaq Stock Market.
Although there is no assurance, we expect that the shareholder proposal at our scheduled December 2, 2022 Annual Shareholders Meeting, for which we have obtained a quorum, to provide the Board of Directors with the discretion to effect a reverse stock split, will enable us to regain compliance with Nasdaq’s minimum bid-price requirement for continued listing on the Nasdaq Capital Market.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Item
Description
99.1
Press Release dated November 15, 2022, titled “Cosmos Health Reports Third Quarter 2022 Financial Results”
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 16, 2022 By: /s/ George Terzis
George Terzis
Chief Financial Officer
3
Aug 23, 2022
cosm_8k.htm0001474167false00014741672022-08-222022-08-22iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 22, 2022
Cosmos Holdings Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
141 West Jackson Blvd, Suite 4236, Chicago, Illinois
60604
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 865-0026
N/A (Former name or former address, if changed since last report.)
Title of Each Class
Trading Symbol
Name of Each Exchange On Which Registered
Common Stock, $.001 par value
Nasdaq Capital Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition
A copy of the press release dated August 22, 2022 of Cosmos Holdings, Inc. (d/b/a Cosmos Health, Inc.) titled “Cosmos Health Reports 202.42% Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022” is filed as Exhibit 99.1 to this Report on Form 8-K. The release contains additional non-public information to that contained in the Company’s current report on Form 10-Q filed with the SEC on August 19, 2022
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Item
Description
99.1
Press Release dated August 22, 2022, titled “Cosmos Health Reports 202.42% Increase in Adjusted EBITDA and Positive Operating Income for the First Half of 2022”
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: August 23, 2022 By: /s/ George Terzis
George Terzis
Chief Financial Officer
3
May 18, 2022
cosm_8k.htm0001474167false00014741672022-05-182022-05-18iso4217:USDxbrli:sharesiso4217:USDxbrli:shares
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 18, 2022
Cosmos Holdings Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
141 West Jackson Blvd, Suite 4236, Chicago, Illinois
60604
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 865-0026
N/A (Former name or former address, if changed since last report.)
Title of Each Class
Trading Symbol
Name of Each Exchange On Which Registered
Common Stock, $.001 par value
Nasdaq Capital Market
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Calculation
On May 18, 2022, Cosmos Holdings Inc. (the “Company”) announced its financial results for the first quarter ended March 31, 2022. A copy of the press release titled “Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022” is filed as Exhibit 99.1 to this Report.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit 99.1 Press Release dated May 18, 2022 titled “Cosmos Holdings Reports 12.5% Increase in Revenue, 88.9% Increase in Gross Profit and Achieves Profitability for the First Quarter of 2022”
104 Cover Page Interactive Data File (embedded within the Inline XBRL Document).
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 18, 2022 By: /s/ George Terzis
George Terzis
Chief Financial Officer
3
May 18, 2021
8-K 1 cosm_8k.htm
cosm_8k.htm
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) May 18, 2021
Cosmos Holdings Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(CommissionFile Number)
(I.R.S. EmployerIdentification No.)
141 West Jackson Blvd, Suite 4236, Chicago, Illinois
60604
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 865-0026
N/A (Former name or former address, if changed since last report.)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Item 2.02 Result of Operations and Financial Condition
On May 18, 2021, Cosmos Holdings, Inc. (the “Company”) issued a press release announcing financial results for the first quarter of 2021. A copy of the press release titled “Cosmos Holdings Provides First Quarter 2021 Business Update; Reports 89% Year-Over-Year and 60% Sequential Increase in Nutraceutical Business” is attached hereto as 99.1 and is incorporated herein by reference. This information is intended to be furnished under this Item 2.02 of Form 8-K and shall not be deemed “Filed” for purposes of Section 18 of the Securities Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit 99.1
Press Release dated May 18, 2021
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 18, 2021 By: /s/ Grigorios Siokas
Grigorios Siokas
Chief Executive Officer
3
Nov 17, 2020
8-K 1 cosm_8k.htm
cosm_8k.htm
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) November 17, 2020
Cosmos Holdings Inc.
(Exact name of registrant as specified in its charter)
Nevada
000-54436
27-0611758
(State or other jurisdiction of incorporation)
(Commission File Number)
(I.R.S. Employer Identification No.)
141 West Jackson Blvd, Suite 4236, Chicago, Illinois
60604
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code (312) 865-0026
N/A (Former name or former address, if changed since last report.)
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13a-4(c))
Item 2.02 Result of Operations and Financial Condition
On November 17, 2020 Cosmos Holdings, Inc. (the “Company”) issued a press release announcing financial results for the third quarter of 2020. A copy of the press release titled “Cosmos Holdings, Inc. Reports Record Third Quarter and Nine-Month Financial Results” is attached hereto as Exhibit 99.1 and is incorporated herein by reference. This information is intended to be furnished under this Item 2.02 of Form 8-K and shall not be deemed “Filed” for purposes of Section 18 of the Securities Exchange Act of 1934 as amended, (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933 as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit 99.1
Press Release dated November 17, 2020
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: November 17, 2020 By: /s/ Grigorios Siokas
Grigorios Siokas
Chief Executive Officer
3
This page provides Cosmos Health Inc. (COSM) earnings call transcripts from SEC 8-K filings along with AI-powered predictions for post-earnings price movements. Our machine learning models analyze historical earnings data, pre-earnings price patterns, volume changes, and volatility to predict 1-day, 5-day, and 20-day returns after each earnings release.
Earnings transcripts are sourced directly from SEC EDGAR filings. Predictions are generated using gradient boosting models trained on COSM's historical earnings reactions. All predicted returns are shown as percentages, and predicted prices are calculated from the closing price at the time of prediction. Past performance does not guarantee future results.